You are here

glioblastoma

First Patient Treated Under Right to Try Law

First Patient Treated Under Right to Try Law

RAPS.org

Flag link:

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

CP Wire

Flag link:

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial

Flag link:

Two papers open door to T cell brain entry for glioblastoma therapy

Two papers open door to T cell brain entry for glioblastoma therapy

BioCentury

Flag link:

Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains

Poliovirus treatment for glioblastoma posts 'encouraging' survival data, but work remains

Fierce Biotech

Duke University

Flag link:

Why ZIOPHARM Oncology, Inc. Stock Broke Out in May

Why ZIOPHARM Oncology, Inc. Stock Broke Out in May

Motley Fool

right-to-try laws

Flag link:

Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster

Northwest Bio's long-awaited glioblastoma vaccine data see stock roller coaster

Fierce Biotech

Northwest Biotherapeutics

dendritic cell vaccines

clinical trials

Flag link:

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down

Endpoints

clinical trials

VBL Therapeutics

Flag link:

The Fastest Growing Cancer Company You've Never Heard Of

The Fastest Growing Cancer Company You've Never Heard Of

Motley Fool

tumor treating fields

pancreatic cancer

Flag link:

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma

Endpoints

Bristol-Myers Squibb

clinical trials

Flag link:

FDA Allows Ziopharm Brain Cancer Drug Trial

FDA Allows Ziopharm Brain Cancer Drug Trial

Investopedia

clinical trials

Flag link:

CAR-T therapy makes early inroads in treating brain cancer

CAR-T therapy makes early inroads in treating brain cancer

Stat

Flag link:

Celgene CEO: myeloma and glioblastoma both priorities

Celgene CEO: myeloma and glioblastoma both priorities

BioPharma Dive

Multiple Myeloma

Flag link:

3 Shocking Biotech Flops of 2016 So Far

3 Shocking Biotech Flops of 2016 So Far

Motley Fool

Celldex Therapeutics

Clovis Oncology

NewLink Genetics

algenpantucel-L

pancreatic cancer

Flag link:

AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting

AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting

Yahoo

Flag link:

CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors

CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors

phys.org

Threshold Pharmaceuticals

Flag link:

Northwest Bio Fuzzier on Cancer Vaccine Study Patient Enrollment

Northwest Bio Fuzzier on Cancer Vaccine Study Patient Enrollment

TheStreet.com

Northwest Biotherapeutics

Flag link:

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting

ImmunoCellular Therapeutics Presents Updated ICT-107 Phase II Data in Patients with Newly Diagnosed Glioblastoma at the 2014 ASCO Annual Meeting

Yahoo/PR NewsWire

ImmunoCellular Therapeutics

Flag link:

Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict

Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict

Bloomberg

Flag link:

Agenus: How Meaningful Is The Prophage Phase II Data?

Agenus: How Meaningful Is The Prophage Phase II Data?

Seeking Alpha

Flag link:

Pages